瑞醇通过调节cAMP/cGMP和PI3K/MAPK通路而产生抗血小板作用
Ga Hee Lee1, Jin Pyo Lee1, Akram Abdul Wahab2
1Department of Biomedical Laboratory Science, Namseoul University, Cheonan 31020, Republic of Korea.
Biomolecules & therapeutics
|December 1, 2025
概括
瑞醇是一种黄类化合物,通过调节循环核酸和激酶通路,有效抑制血小板聚合. 这种天然化合物显示出预防血栓性心血管事件的潜力.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 心血管研究研究心血管研究
背景情况:
- 瑞醇是来自传统草药的黄胺,具有抗炎和抗氧化特性.
- 它的潜在抗血小板活性表明它在预防心血管疾病方面起着作用.
研究的目的:
- 为了阐明瑞醇抗血小板作用背后的分子机制.
- 研究瑞醇对血小板激活通路的影响.
主要方法:
- 评估了原诱导的血小板聚合和细胞毒性.
- 测量了细胞内循环AMP (cAMP) 和循环GMP (cGMP) 的水平.
- 分析了IP3R,PI3K,Akt,JNK,p38 MAPK的酸化和的调动.
主要成果:
- 瑞醇抑制了血小板聚合,没有细胞毒性.
- 增加了cAMP/cGMP,增强了IP3R酸化,并减少了Ca2+调动.
- 抑制PI3K/Akt/JNK/p38 MAPK通路,降低cPLA2和TXA2的产生.
- 降低血素A2 (TXA2) 的分泌和密集颗粒的释放 (ATP,血清素).
- 失效的血栓收缩,由血栓诱导.
结论:
- 瑞醇表现出多目标抗血小板机制.
- 调节循环核酸,激酶信号和血小板功能.
- 作为预防血栓性心血管事件的潜在治疗剂.
相关概念视频
cAMP-dependent Protein Kinase Pathways
8.2K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.2K
GPCRs Regulate Adenylyl Cylase Activity
7.2K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.0K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.0K
IP3/DAG Signaling Pathway
14.2K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
14.2K
Calmodulin-dependent Signaling
6.0K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
6.0K
Amplifying Signals via Enzymatic Cascade
17.0K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
17.0K


